Blood coagulation analyzer and reagents do/to
Ended Awarded Last action
- Contract number
- W81K0425FA238
- Awardee
-
Werfen USA LLC UEI JA87HT8KP2M2
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $108,658
Award facts
- Contract value 100% obligated
- $108,657.52 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6630 Chemical Analysis Instruments
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Fayetteville, NC 28314, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Funding Only Action | $108,658 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
About this award
The Defense Health Agency awarded a $108,657.52 delivery order to Werfen USA LLC for blood coagulation analyzer and reagents with a performance period from October 1, 2025 through September 30, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, and performance will occur at a location in Fayetteville, North Carolina. Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and clinical laboratory instrumentation, is well-established in the federal marketplace as a full-sized contractor with an extensive portfolio of coagulation testing equipment and reagent supply contracts.
This delivery order likely derives from one of Werfen's existing indefinite delivery vehicle contracts with the Defense Health Agency, which maintains multiple master agreements with the company for automated blood coagulation and hemostasis testing analyzer reagents. The award supports the Department of Defense's medical treatment facility operations through the provision of coagulation diagnostic equipment and associated consumables. Werfen's significant federal contracting experience includes similar coagulation testing agreements with multiple Veterans Integrated Service Networks valued in the millions of dollars, demonstrating the company's capability to reliably supply critical laboratory diagnostic equipment and reagents to federal healthcare systems on a consistent basis.
Quick answers
Who was awarded contract W81K0425FA238?
W81K0425FA238 was awarded to Werfen USA LLC by Medical Command (Department of the Army) on October 1, 2025.
How much is contract W81K0425FA238 worth?
The government has obligated $108,658 on W81K0425FA238.
Which agency awarded contract W81K0425FA238?
Medical Command (Department of the Army) awarded W81K0425FA238, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0425FA238 an order under another contract?
Yes. W81K0425FA238 is a delivery order under W91YTZ25DA002, an indefinite delivery contract.
Was contract W81K0425FA238 competed?
The extent of competition for W81K0425FA238 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award